Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6182 of 6351
-
Could a new mouthwash formula be kinder to your gums?
Knowledge-focused Not yet recruitingThis prospective in vitro study aims to evaluate the effects of two chlorhexidine-based mouthwash formulations on the survival and function of human gingival fibroblasts (hGFs). Gingival fibroblasts obtained from discarded gingival tissue collected during routine dental procedure…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Smartphone exercise app tested for seniors – but study pulled
Knowledge-focused CancelledThe purpose of this study is to investigate the effectiveness and usability of a Gingko app based exercise training in middle and older aged adults. The main question it aims to answer is if the personalized Gingko app-based exercise is more effective in improving overall physica…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Will breakfast change how this diabetes drug works?
Knowledge-focused Not yet recruitingThis is a single dose, randomized, open-label, two-way crossover study to investigate the food-effect bioavailability of the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg in healthy volunteers under fasting and fed conditions.
Phase 1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Finger length may reveal hidden motor skills, study says
Knowledge-focused By invitation onlyDue to the difficulties and risks of directly measuring prenatal hormone levels, biomarkers that indirectly reflect this exposure are used in research. In this context, the ratio of second to fourth finger length (2D:4D) is widely preferred because it is an easily applicable and …
Sponsor: Nigde Omer Halisdemir University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Scientists to track tiny metabolism changes in healthy adults
Knowledge-focused Not yet recruitingThis prospective observational study aims to characterize within-individual variability in resting metabolic rate (RMR) over a 12-week period using high-frequency repeated measurements under standardized conditions. Participants will undergo RMR assessments three times per week u…
Sponsor: Tel Aviv University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Heart bypass device under review in 20-Patient safety check
Knowledge-focused Not yet recruitingPrior to the implementation of the Medical Device Regulation (MDR), clinical evaluation of older devices was carried out by Notified Bodies (MBs) based on clinical data obtained from equivalent devices, and CE certification was granted to devices exhibiting similar characteristic…
Sponsor: Bıçakcılar Tıbbi Cihazlar Sanayi ve Ticaret A.Ş. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New cancer drug trial pulled before it even started
Disease control CancelledPhase I: Characterize safety and tolerability of ERW316 as a single agent and in combination with fulvestrant or letrozole. Identify dose range for optimization/recommended dose for further clinical evaluation. Phase II: Further characterize the safety and tolerability of ERW316…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Will breakfast or heartburn pills change how this new drug works?
Knowledge-focused OngoingThis is a single-center, open-label, randomized, four-period, six-sequence study with a planned enrollment of 24 healthy participants. The study consists of a screening period, a dosing period (Cycles 1, 2, 3, and 4), and a follow-up period. Screening must occur within 14 days pr…
Phase 1 • Sponsor: Hutchmed • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Bladder cancer drug trial pulled before it even started
Disease control CancelledThis is a Phase 3, open-label single-arm trial designed to evaluate the safety and efficacy of NDV-01 (sustained-release gemcitabine-docetaxel) in adult participants with NMIBC with CIS who have failed BCG therapy and who have failed first-line therapy for BCG-unresponsive NMIBC …
Phase 3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Early study checks how food and common drugs change MK-8527 levels
Knowledge-focused OngoingResearchers are studying a medicine called MK-8527 to learn how it behaves in the body of healthy adults. The goal of this study is to learn about the effect of MK-8527 when it is taken with food or with other medicines. Researchers also want to learn about the safety of MK-8527…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New drug AZD7760 tested in healthy volunteers for safety
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the safety and PK of AZD7760 when given as an intravenous (IV) infusion to healthy Japanese adult participants.
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New malaria drug interaction study launches in healthy volunteers
Knowledge-focused Recruiting nowThis study aims to evaluate whether GSK3772701 alters the pharmacokinetics (PK) of midazolam (MDZ), a standard probe substrate for the CYP3A4 enzyme. The findings are planned to be used to determine whether GSK3772701 acts as an inducer and/or inhibitor of CYP3A4 and will help gu…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New drug FB102 begins first human safety tests
Knowledge-focused Recruiting nowThe purpose of this Phase 1 trial is to evaluate the safety and effects of FB-102 in healthy volunteers following single and multiple doses.
Phase 1 • Sponsor: Forte Biosciences, Inc. • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Healthy volunteers needed to compare two forms of a cholesterol drug
Knowledge-focused CompletedA randomized, open-label, single-dose, 2-sequence, 2-period, crossover clinical trial to investigate the bioequivalence between YHP2511 and YHP2511A in healthy volunteers
Phase 1 • Sponsor: Yuhan Corporation • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New Drug's breast milk levels under the microscope
Knowledge-focused Recruiting nowThe main purpose of this study is to assess the concentrations of nipocalimab (pharmacokinetics \[PK\]) in the breast milk after administration of a single dose of nipocalimab into the vein, in healthy lactating women.
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Drug interaction study: bosentan may change zongertinib levels
Knowledge-focused CompletedThe main objective of this trial is to investigate the effect of a moderate CYP 3A inducer bosentan on the pharmacokinetics of zongertinib.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New blood thinner tested in small chinese heart study
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the pharmacokinetics (PK), pharmacodynamics, and tolerability of a single dose of selatogrel in Chinese adults with chronic coronary syndrome. Pharmacokinetics is the study of the absorption and breakdown of the study drug in the body. Ph…
Phase 1 • Sponsor: Viatris Innovation GmbH • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Could a breath of hydrogen boost your workout? small study investigates
Knowledge-focused Recruiting nowThe goal of this clinical trial is to evaluate if molecular hydrogen can reduce the metabolic response during graded exercise in healthy women aged 18-30 years. The main questions it aims to answer are: * Does molecular hydrogen reduce the respiratory exchange ratio? * Does mole…
Sponsor: Palacky University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Osteoporosis drug studied for spine surgery recovery – but trial pulled
Disease control CancelledThe goal of this clinical trial is to learn if romosozumab (Evenity) can improve bone and muscle health in postmenopausal women with osteoporosis who are undergoing lumbar spine surgery. The main questions it aims to answer are: * Does romosozumab improve bone strength and reduc…
Phase 2 • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Bigger gastric tool tested in tiny trial
Knowledge-focused Not yet recruitingThis study investigates the use of the large diameter ViSiGi LUX ™
Sponsor: Boehringer Labs LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC